Received Jan 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Pain full shots; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine with an associated reaction of pain (received 1st dose on an unknown date refer case US2026AMR005179). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Pain full shots). (Dechallenge was positive). Rechallenge with Shingles vaccine was positive. The outcome of the pain was not reported. It was unknown if the reporter considered the pain to be related to Shingles vaccine. It was unknown if the company considered the pain to be related to Shingles vaccine. Additional Information: GSK Receipt Date-11-JAN-2026 This case was reported by a patient via interactive digital media. The patient stated that the two shingles vaccine doses were among the most painful injections the patient had ever received. The patient acknowledged that receiving the vaccination was still preferable to the alternative of contracting shingles. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: US-GSK-US2026AMR005179:Case for 1st dose